Basal Tumours in Bladder Cancer Response to chemoTherapy

  • STATUS
    Recruiting
  • days left to enroll
    54
  • participants needed
    500
  • sponsor
    University Hospital, Rouen
Updated on 23 January 2021

Summary

Determine the sensitivity/resistance to chemotherapy of the various subgroups of muscle-invasive bladder cancers, including the basal subgroup (about 25% of these tumours) according to 4 different classifications based on molecular or immunohistochemical classifiers.

Details
Condition urinary tract neoplasm, Urologic Cancer, bladder cancer, bladder cancer, Bladder Carcinoma, Urothelial Cancer, bladder disorder, Bladder Disorders, Chemotherapy Effect, Urothelial Cancer, Bladder Disorders, Bladder Carcinoma, Urologic Cancer, carcinoma of the bladder, bladder tumor
Treatment neoadjuvant chemotherapy with cisplatine
Clinical Study IdentifierNCT04089748
SponsorUniversity Hospital, Rouen
Last Modified on23 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Tumors from patient having muscle invasive bladder cancer who benefit from
neoadjuvant chemotherapy with cisplatine included in VESPER cohort and
having signed an informed consent form for the participation to the collection or
dead/lost to follow-up without prior opposition expressed against research program
genetic analysis will only be carried out for patients who have signed the genetic consent form
Inclusion Criteria of Patients from St Louis cohort not enrolled in VESPER
study
Tumors from patient having muscle invasive bladder cancer who benefit from
neoadjuvant chemotherapy with cisplatine included in Saint-Louis cohort and
having received an informed form for the participation to the collection and not having expressed opposition against research program within 1 month or
dead/lost to follow-up without prior opposition expressed against research program

Exclusion Criteria

Patients enrolled in VESPER study:Tumors from patient having withdrawn his/her informed consent form for the participation to the collection and/or VESPER project
OR
Patients from St Louis not enrolled in VESPER study:Tumors from patient having expressed opposition against research program after 1 month for the participation to the collection
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note